Abnormal Aortic Morphology

Introduction

Abnormal aortic morphology encompasses a range of structural deviations in the aorta, the body’s main artery, and its associated valves. These conditions can significantly impact cardiovascular health, leading to various diseases such as aortic valve stenosis, aortic root dilation, and aneurysms. Understanding the genetic and environmental factors contributing to these abnormalities is crucial for early detection, risk assessment, and effective management.

Background

The aorta, a vital component of the circulatory system, can develop several structural abnormalities. Aortic valve stenosis (AS), for instance, is characterized by the thickening and calcification of the aortic valve cusps, leading to obstruction of blood flow from the left ventricle. This progressive condition affects approximately 5% of individuals over 70 years of age and, if severe and symptomatic, carries a significant risk of morbidity and mortality, with estimated 5-year survival rates ranging from 15% to 50% without aortic valve replacement.^[1]The pathogenesis of AS is not fully understood, but it shares several clinical risk factors with atherosclerotic disease, and calcified aortic valve lesions exhibit characteristics such as endothelial damage, oxidized lipid deposition, chronic inflammation, and calcification.^[1]

Another common abnormality is the bicuspid aortic valve (BAV), a congenital heart defect where the aortic valve has two leaflets instead of the typical three. BAV is recognized for accelerating the development of AS by decades. ^[1] Beyond valvular issues, the aorta itself can undergo structural changes, such as aortic root dilation, which can lead to severe aortic regurgitation. ^[2] Furthermore, the aorta can be affected by aneurysms, which are abnormal bulges or dilatations in the arterial wall. These can occur in different locations, including intracranial, abdominal (AAA), and thoracic (TAA) regions. ^[3]

Biological Basis

Genetic factors play a substantial role in the predisposition to abnormal aortic morphology. For example, the relationship between BAV and aortopathy (any disease of the aorta) is well-established, with dilation of the proximal ascending aorta often resulting from altered blood flow patterns caused by the BAV.^[1] Research has identified specific genetic variants associated with these conditions. A variant, rs7543130 , located near the PALMDgene on chromosome 1p21, has been linked to an increased aortic root size, as well as an elevated risk for AS and BAV.^[1]Interestingly, the impact of this variant on aortic root size appears to be largely independent of BAV, as its association remains significant even when BAV cases are excluded from analysis.^[1] In contrast, a missense variant in MYH6has a strong effect on BAV but does not significantly influence aortic root size.^[1] This MYH6 variant has also been associated with non-syndromic coarctation of the aorta, sick sinus syndrome, and atrial fibrillation. ^[4]

Other genetic loci are also implicated in aortic morphology. For instance, rs17696696 , an intronic variant in CFDP1, has been associated with aortic root size.^[1] There are also shared genetic risk factors among different types of aneurysms, including intracranial, abdominal, and thoracic aneurysms. ^[3] Mutations in genes such as FBN1 are known to cause Marfan syndrome, a connective tissue disorder frequently associated with aortic aneurysms, particularly in the thoracic region. ^[3] Additionally, mutations in TGFBR1 and TGFBR2 have been identified in families exhibiting all three types of aneurysms. ^[3]Genetic variations, such as a variant in low-density lipoprotein receptor-related protein 1 (LRP1), have been linked to abdominal aortic aneurysm.^[5] Furthermore, genetic variation at the LPA locus, specifically rs10455872 , has been causally linked to aortic valve calcification and clinical calcific aortic-valve disease, with its effect mediated by lifelong elevations in Lp(a) levels.^[6]

Clinical Relevance

Abnormal aortic morphology holds significant clinical relevance due to its potential for severe health consequences. Conditions such as severe aortic valve stenosis can lead to substantial morbidity and mortality if left untreated, necessitating interventions like aortic valve replacement.^[1] Bicuspid aortic valve, a common congenital defect, is known to accelerate the progression of AS, highlighting the importance of early diagnosis and monitoring in affected individuals. ^[1] Aortic root dilation can result in serious complications such as aortic regurgitation ^[2] while thoracic aortic aneurysms and aortic dissections represent life-threatening emergencies. ^[7]Identifying genetic predispositions to these conditions can enable improved screening protocols, earlier intervention, and more personalized management strategies, potentially altering disease trajectories and improving patient outcomes.

Social Importance

The pervasive nature of abnormal aortic morphology, affecting a considerable portion of the aging population, underscores its broader social importance. For example, aortic stenosis affects 5% of individuals over 70, indicating a substantial public health burden.^[1]Understanding the underlying genetic architecture of these conditions can lead to advancements in population-level risk stratification and prevention programs. By identifying individuals at higher genetic risk, healthcare resources can be more effectively allocated for targeted screening and preventive measures. The discovery of shared genetic risk factors among different types of aneurysms, for instance, emphasizes the need for a holistic approach to cardiovascular health, potentially informing broader public health initiatives.^[3]Ultimately, insights into abnormal aortic morphology contribute to reducing disease incidence, improving quality of life, and decreasing the societal and economic impact associated with advanced cardiovascular disease.

Limitations

Methodological and Statistical Constraints

Research into abnormal aortic morphology faces several methodological and statistical limitations that impact the precision and interpretability of findings. Phenotypic and study design heterogeneity across different investigations can diminish statistical power, making it challenging to detect modest genetic effects, particularly in genome-wide association studies.^[8] Measurement errors, such as the potential underestimation of aortic diameter by M-mode echocardiography compared to 2-dimensional imaging, can bias estimates towards the null hypothesis of no association. ^[8]Furthermore, studies often have limited statistical power to evaluate associations with rare single nucleotide polymorphisms (SNPs) or those that are poorly imputed, leading to an incomplete understanding of the full genetic landscape.^[8]

Small sample sizes in some cohorts also contribute to reduced statistical power, limiting the ability to detect significant associations or to confidently replicate findings. ^[9]This is further exacerbated by challenges in replicating positive associations, even in large-scale genome-wide association studies for common cardiovascular diseases, suggesting that some initial findings may not be robust.^[10] Such issues highlight the need for larger, more harmonized studies with rigorous phenotyping to improve the detection and replication of genuine genetic effects.

Phenotypic Heterogeneity and Generalizability

Defining and measuring abnormal aortic morphology presents significant challenges, as the trait itself can encompass a spectrum of conditions with varying etiologies. For instance, studies sometimes lack detailed information on whether aortic valve stenosis occurred on the background of a bicuspid or tricuspid valve, which can obscure specific genetic associations related to distinct forms of valve pathology.^[1]Cohort selection can also introduce biases; for example, if cases are predominantly drawn from patients undergoing surgery for aortic valve replacement or aneurysm repair, the study population may be skewed towards more severe or advanced disease states, limiting generalizability to individuals with milder forms or earlier stages of the condition.^[1]

A notable limitation in many genetic studies is the predominant focus on populations of European ancestry, which restricts the generalizability of findings to other ethnic groups. ^[1]This is particularly critical given that populations like African Americans are known to be at increased risk for adverse cardiovascular outcomes, including arterial stiffness and hypertension, yet are often underrepresented in large genetic studies.^[10] Differences in genetic architecture and environmental exposures across diverse populations mean that variants identified in one group may not hold the same effect or even be present in another, underscoring the need for more inclusive research to capture the full spectrum of genetic risk.

Unexplained Heritability and Complex Interactions

Despite advances in genetic research, a substantial proportion of the heritability for complex traits like abnormal aortic morphology remains unexplained by identified genetic variants, a phenomenon often referred to as “missing heritability”.^[10] This suggests that the current understanding, largely based on common genetic variants, may not fully capture the genetic architecture of these conditions. Complex diseases are likely mediated by multiple pathophysiologic processes, and their development is influenced by an intricate interplay between genetic predispositions and environmental factors. ^[10]

The impact of environmental or gene-environment confounders is often difficult to fully ascertain and control for, yet these factors can significantly modulate the expression of genetic risk. For instance, while genetic variants may increase susceptibility to aortic enlargement, lifestyle, comorbidities, and other extrinsic factors undoubtedly play a crucial role in disease manifestation and progression. Future research needs to better integrate environmental data and explore gene-environment interactions to bridge these remaining knowledge gaps and provide a more comprehensive understanding of the etiology of abnormal aortic morphology.

Variants

The genetic landscape of aortic health involves a complex interplay of genes that regulate vascular development, extracellular matrix integrity, and cellular signaling pathways. Among these, variants in genes like VSTM2B-DT and VDRhave garnered attention for their potential roles in predisposing individuals to abnormal aortic morphology. These genes contribute to distinct biological processes, yet their combined influence can shed light on the multifactorial nature of aortic conditions.

The VSTM2B-DT gene (V-set and transmembrane domain containing 2B-DT) is a less characterized gene, often studied in the context of its neighboring gene, VSTM2B. It is thought to play a role in cell adhesion, differentiation, and tissue development, processes critical for the structural integrity and proper formation of the aorta. Variants within this region, such as rs892076 , may influence the expression levels or functional activity of VSTM2B-DT, thereby impacting the complex biological pathways involved in maintaining arterial wall health.. ^[11] Alterations in these pathways can contribute to the weakening or abnormal remodeling of the aortic wall, increasing susceptibility to conditions like aortic aneurysms or dissections. .

The VDRgene encodes the Vitamin D Receptor, a nuclear receptor that mediates the biological actions of vitamin D, a crucial secosteroid hormone. Vitamin D signaling is vital for calcium and phosphate homeostasis, bone metabolism, and immune regulation, but it also plays significant roles in cardiovascular health, including modulating vascular smooth muscle cell proliferation, inflammation, and arterial stiffness..^[12] The rs73111983 variant, also known as FokI, is a common polymorphism within the VDRgene that can affect the translation initiation site, leading to two different protein isoforms with varying transcriptional activities. This functional change can alter the efficiency of vitamin D signaling, potentially impacting vascular tone, calcification, and overall aortic structural integrity, thereby influencing the risk of abnormal aortic morphology..^[11]

The interplay between these genetic factors highlights the intricate mechanisms underlying aortic health. While VSTM2B-DT variants like rs892076 may directly affect the structural components and developmental processes of the aorta, VDR variants like rs73111983 can modulate systemic factors such as inflammation and calcification, which indirectly but significantly contribute to aortic pathology. . Understanding the combined effects of these and other genetic variants provides a more comprehensive view of an individual’s predisposition to abnormal aortic morphology, paving the way for more personalized risk assessments and potential therapeutic strategies. .

Key Variants

RS ID	Gene	Related Traits
rs892076	VSTM2B-DT	abnormal aortic morphology
rs73111983	VDR	abnormal aortic morphology

Classification, Definition, and Terminology

Defining Abnormal Aortic Morphology and Subclinical Atherosclerosis

Abnormal aortic morphology refers to deviations from the typical structure of the aorta, a major artery responsible for transporting oxygenated blood from the heart to the rest of the body. Within the context of cardiovascular health, these morphological abnormalities are often conceptualized as manifestations of subclinical atherosclerosis, a disease characterized by the hardening and narrowing of arteries due to plaque buildup, occurring before clinical symptoms become apparent.^[13]A key operational definition for this trait, particularly in research settings, is the presence of abdominal aortic calcification (AAC), which signifies calcium deposits within the walls of the abdominal aorta. This specific type of abnormality serves as a measurable indicator of systemic atherosclerotic burden, alongside other markers like coronary artery calcification (CAC) and intimal medial thickness (IMT) in major arterial territories.^[13]

Terminology and Diagnostic Measurement

The primary terminology associated with identifying abnormal aortic morphology in a subclinical context centers on abdominal aortic calcification (AAC). This term precisely describes the mineral deposition in the abdominal aorta, which is a tangible marker of arterial wall pathology. The diagnostic and measurement approach for AAC frequently employs multidetector Computed Tomography (MDCT).^[13]MDCT allows for detailed visualization and quantification of calcified plaques within the aortic wall, providing a precise assessment of the extent and distribution of these abnormalities. This imaging modality offers a non-invasive means to assess the trait, establishing a research criterion for identifying individuals with subclinical atherosclerosis.^[13]

Classification and Clinical Significance

The identification of abnormal aortic morphology, particularly through the assessment of AAC, contributes to the classification of individuals based on their atherosclerotic burden. The term “subclinical atherosclerosis” itself denotes a classification, categorizing individuals who exhibit signs of the disease without experiencing overt symptoms, distinguishing them from those with clinically manifest cardiovascular disease. While specific severity gradations for AAC are not detailed here, the presence and quantification of calcification via MDCT inherently allow for a dimensional approach to assessing disease progression, with higher scores typically indicating more extensive disease. Such findings are significant as they highlight individuals at an elevated risk for future cardiovascular events, even in the absence of traditional clinical indicators.^[13]

Signs and Symptoms

Clinical Manifestations and Associated Conditions

Abnormal aortic morphology encompasses a broad spectrum of conditions, ranging from congenital anomalies to acquired degenerative diseases, with clinical presentations varying significantly. Many forms can remain asymptomatic for extended periods, being discovered incidentally during imaging for other conditions.^[3]For instance, coarctation of the aorta, a congenital narrowing, can manifest differently depending on age, potentially presenting with symptoms related to reduced blood flow or hypertension.^[4] Aortic aneurysms, including abdominal aortic aneurysms (AAA) and thoracic aortic aneurysms (TAA), are often silent but carry a risk of severe complications like dissection if left undiagnosed and untreated. ^[3]

Conditions affecting the aortic valve, such as aortic valve stenosis (AS) or a bicuspid aortic valve (BAV), can lead to progressive obstruction or altered hemodynamics, eventually causing symptoms like chest pain, shortness of breath, or syncope as the disease advances.^[1]Aortic root dilation, a specific morphological abnormality, is recognized as a cause of isolated, severe aortic regurgitation, which can subsequently impact left ventricular hypertrophy and function.^[10]The presence of these diverse aortic pathologies underscores the importance of early detection and monitoring due to their potential for serious cardiovascular morbidity and mortality.

Diagnostic Assessment and Measurement Approaches

The objective assessment of abnormal aortic morphology primarily relies on advanced imaging techniques, which provide detailed anatomical and functional information. Echocardiography serves as a foundational diagnostic tool for evaluating aortic root size and valve morphology, playing a crucial role in identifying conditions such as bicuspid aortic valve (BAV), aortic stenosis, and aortic regurgitation.^[1]This non-invasive method allows for precise measurements and serial monitoring of disease progression over time.

Computed tomography (CT) scans are widely utilized for the visualization and quantification of aortic calcification, including abdominal aortic calcification (AAC) and coronary artery calcification (CAC), which are significant indicators of subclinical atherosclerosis.^[13] CT also offers a comprehensive view for the diagnosis and surveillance of various aortic aneurysms, such as abdominal, thoracic, and intracranial aneurysms, as well as aortic dissections, by providing accurate measurements of aortic diameter and shape. ^[9]These imaging modalities, often complemented by covariate adjustment for factors like blood pressure, are essential for characterizing the extent of aortic disease and guiding clinical management strategies.^[13]

Genetic Influences and Phenotypic Heterogeneity

Abnormal aortic morphology exhibits considerable inter-individual variation and phenotypic diversity, frequently influenced by underlying genetic factors. Bicuspid aortic valve (BAV), a common congenital heart defect, demonstrates a strong genetic component and is often associated with aortic dilation.^[14]Genome-wide association studies (GWAS) have successfully identified specific genetic loci associated with key aortic traits, including aortic root size and calcific aortic valve stenosis, thereby highlighting the heritable nature of these conditions.^[1]

Variability is also evident in age-related changes and sex differences, with distinct genetic risk variants identified for certain phenotypes like abdominal aortic aneurysms. ^[9] While specific genetic mutations, such as a missense variant in MYH6, can have a substantial effect on BAV, their impact on aortic root size may be minimal, indicating complex genotype-phenotype correlations.^[1]This genetic heterogeneity further reveals that shared genetic risk factors can exist across different aneurysm types—intracranial, abdominal, and thoracic—but their clinical expression and penetrance can vary significantly among individuals and families.^[3]

Causes of Abnormal Aortic Morphology

Abnormal aortic morphology, encompassing conditions like aortic dilation, aneurysms, and valvular stenosis, results from a complex interplay of genetic predispositions and acquired factors. These causal elements often converge to disrupt the structural integrity and function of the aorta, leading to progressive changes in its size, shape, and mechanical properties.

Genetic Predisposition and Congenital Abnormalities

Genetic factors play a fundamental role in determining an individual’s susceptibility to abnormal aortic morphology, ranging from rare Mendelian disorders to common polygenic risks. Mutations in single genes, such asNOTCH1, are known to cause aortic valve disease, highlighting a strong inherited component in some cases.^[15] The familial aggregation of calcific aortic valve stenosis further underscores the heritable nature of these conditions. ^[16] Common genetic variants also contribute significantly; for instance, a variant near PALMD, rs7543130 , is associated with both bicuspid aortic valve (BAV) and increased aortic root size, and its impact on aortic root size is not solely a consequence of BAV.^[1] Another variant, rs17696696 intronic to CFDP1, has also been linked to aortic root size.^[1]

The bicuspid aortic valve itself is a congenital abnormality with a strong genetic component ^[14] and its presence is well recognized to relate to aortopathy, where changes in blood flow secondary to BAV are thought to contribute to proximal ascending aortic dilation. ^[1] Beyond specific gene mutations, the collective effect of multiple common genetic variants, known as polygenic risk, contributes to the development of various aortic aneurysms, including thoracic, abdominal, and intracranial types. ^[1] For example, a variant in LRP1has been associated with abdominal aortic aneurysm.^[5] Genetic polymorphisms in genes like APOEhave also been linked to calcific valvular heart disease, influencing lipid metabolism pathways that impact aortic health.^[17]

Molecular Pathways and Connective Tissue Remodeling

The structural integrity and mechanical properties of the aorta are maintained by a complex extracellular matrix, and disruptions in the molecular pathways governing its remodeling can lead to abnormal morphology. Genes involved in regulating arterial stiffness and remodeling, such as those forangiotensin-converting enzyme (ACE) and angiotensin II type 1 receptor (AT1R), have polymorphisms that influence aortic stiffness. ^[11] Similarly, variants in beta-adrenergic receptor genes and endothelingenes are associated with arterial stiffness and aortic structure.^[18] The Matrix metalloproteinase-3 (MMP-3) genotype is another significant contributor, modulating gene and protein expression that affects age-related aortic stiffening. ^[19]

Beyond stiffness, specific genetic loci have been associated with aortic root diameter, including SNPs near CCDC100, HMGA2, and PDE3A, all of which are expressed in aortic tissue. ^[8] While the exact function of CCDC100 in cardiac or vascular tissue remains unclear, HMGA2 encodes a transcriptional regulating factor, suggesting a role in gene expression critical for aortic development or maintenance. ^[8] These molecular pathways highlight the intricate genetic control over the aorta’s physical characteristics and its susceptibility to remodeling processes that can result in abnormal morphology over time.

Systemic Risk Factors and Gene-Environment Interactions

Abnormal aortic morphology is often influenced by systemic conditions and age-related changes, which can interact with an individual’s genetic background. Hypertension is a well-established risk factor that contributes to increased aortic stiffness and can be a covariate in studies of aortic health.^[20]Age itself is a primary driver of aortic stiffening, and its interaction with other factors, such as lipoproteins, can predict aortic valve calcification.^[19] Lipid metabolism also plays a crucial role; for example, genetic variation at the LPA locus (rs10455872 ) is strongly associated with aortic-valve calcification and clinical aortic stenosis, with elevated Lp(a) levels causally linked to an increased prevalence of these conditions.^[6]

Furthermore, specific genetic predispositions can interact with physiological states or environmental influences. For instance, an Oestrogen receptor alpha gene polymorphism is related to aortic valve sclerosis in postmenopausal women, indicating a sex-specific genetic influence on aortic health in certain life stages. ^[21] Similarly, the vitamin D receptor genotype has been shown to predispose individuals to the development of calcific aortic valve stenosis. ^[12]While genetic studies often adjust for risk factors like hypertension, exploratory analyses are sometimes conducted to assess the independence of identified genetic variants from other established risk factors, suggesting a complex interplay rather than isolated effects.^[5]

Biological Background

Genetic Basis and Molecular Signaling in Aortic Integrity

Abnormal aortic morphology often stems from underlying genetic predispositions that impact the structural integrity and regulatory mechanisms of the aorta. Mutations in genes such asFBN1 are known to cause Marfan syndrome, a condition frequently associated with thoracic aortic aneurysms (TAA). ^[3] FBN1encodes fibrillin-1, a crucial component of the extracellular matrix that provides elasticity and strength to connective tissues, including the aortic wall. Disruptions in fibrillin-1 can compromise the structural integrity of the aorta, leading to its dilation and aneurysm formation. Furthermore, mutations inTGFBR1 and TGFBR2, which encode receptors for transforming growth factor-beta, have been identified in families presenting with various aneurysm types, including intracranial, abdominal, and thoracic aneurysms.^[3] These receptors play a vital role in cellular signaling pathways that regulate cell growth, differentiation, and the synthesis and degradation of the extracellular matrix, making their proper function critical for maintaining aortic wall homeostasis.

Beyond specific gene mutations, broader genetic risk factors contribute to abnormal aortic morphology, indicating complex regulatory networks. Shared genetic loci, such as the 9p21.1 region, have been associated with both intracranial and abdominal aortic aneurysms, suggesting common underlying molecular pathways influencing vascular health.^[3] These genetic factors can influence gene expression patterns and cellular functions within the aortic wall, potentially predisposing individuals to vessel weakening and structural changes. The identification of new genetic loci associated with conditions like aortic valve stenosis also highlights the diverse genetic landscape contributing to various forms of aortic abnormalities. ^[1]Understanding these genetic and molecular underpinnings is crucial for unraveling the intricate biological mechanisms that lead to abnormal aortic morphology.

Pathophysiological Mechanisms of Aortic Remodeling

The development of abnormal aortic morphology involves distinct pathophysiological processes that vary depending on the specific location and type of abnormality. Aneurysms, for instance, manifest with different shapes; intracranial aneurysms (IA) are typically saccular, while abdominal aortic aneurysms (AAA) and thoracic aortic aneurysms (TAA) are more often fusiform.^[3]These structural differences reflect variations in the underlying disease mechanisms and the specific tissue responses at each arterial location. Atherosclerosis, a chronic inflammatory disease characterized by plaque buildup, plays a clear and significant role in the pathogenesis of AAA, contributing to vessel wall degradation and dilation.^[3]In contrast, atherosclerosis is less prominent in the development of IA and TAA, which often involve different mechanisms such as connective tissue disorders or genetic predispositions.

Developmental processes can also contribute to abnormal aortic morphology, influencing the initial structure and subsequent remodeling of the aorta. Homeostatic disruptions, such as imbalances in extracellular matrix turnover or chronic inflammation, can initiate and propagate these pathological changes. While some forms of abnormal morphology may be present from birth, others develop over time due to a combination of genetic susceptibility and environmental factors. The vessel wall structure itself differs significantly between the locations where IA, AAA, and TAA occur, influencing their unique pathophysiologies.^[3] Compensatory responses within the body may attempt to counteract these disruptions, but often fail to prevent the progressive weakening and dilation of the aortic wall, ultimately leading to clinical manifestations of abnormal morphology.

Tissue-Level Interactions and Systemic Consequences

Abnormal aortic morphology is not merely a localized defect but often involves complex tissue interactions and can have systemic consequences. The aorta, as the body’s main artery, is subject to constant hemodynamic forces, and any structural compromise can affect blood flow and organ perfusion throughout the body. The vessel wall, composed of layers of smooth muscle cells, endothelial cells, and extracellular matrix, relies on intricate communication and signaling pathways to maintain its integrity and function. When these interactions are disrupted, for example, by mutations in structural proteins or signaling molecules, the tissue can undergo maladaptive remodeling, leading to conditions like aortic dilation or calcification.^[13] These changes can manifest as localized abnormalities but can also indicate a broader vulnerability within the vascular system.

The co-occurrence of different aneurysm types, such as AAA and TAA, and to a lesser extent, IA and aortic aneurysms, points towards shared underlying genetic or systemic factors that predispose individuals to vascular disease.^[3]This suggests that while local environmental factors and hemodynamic stresses play a role, there may be systemic biological processes that increase susceptibility across different arterial territories. Such widespread susceptibility underscores the importance of a comprehensive understanding of how tissue-level biology, including cellular functions and extracellular matrix dynamics, contributes to the overall health and morphology of the aorta and other major arteries. The systemic nature of these conditions highlights the potential for broader cardiovascular implications beyond the immediate site of the abnormality.

Pathways and Mechanisms

Transcriptional and Epigenetic Control of Aortic Development

The intricate process of aortic development and maintenance is profoundly influenced by genetic and epigenetic regulatory mechanisms. Key transcription factors, such as ELF1, ETS2, RUNX1, and STAT5, exhibit differential expression in abdominal aortic aneurysm (AAA) tissue, suggesting their involvement in disease pathogenesis through the regulation of downstream gene expression.^[9] Similarly, HMGA2, a high mobility group AT-hook 2 protein, functions as a transcriptional regulating factor and is associated with aortic root diameter, indicating its role in shaping aortic dimensions. ^[8] Genetic variants in regions like the 3’-BCL11Bgene desert are linked to carotid-femoral pulse wave velocity, influencing arterial stiffness, andCTIP2, a protein that associates with the NuRD complex, regulates the promoter of genes like p57KIP2, further illustrating hierarchical gene regulation in vascular health. ^[20]

Beyond direct transcriptional activation, epigenetic modifications play a crucial role in modulating gene expression in aortic tissues. Studies analyzing aortic valve stenosis have identified associations with specific histone marks, DNAse accessibility, and the configuration of active or poised promoters. ^[1] These regulatory elements, including heterochromatin and Polycomb-group repressed states, influence chromatin structure and gene availability for transcription, thereby dictating cellular phenotypes and responses within the aorta. ^[1] The integration of genomic data, such as Hi-Cassays, provides insights into structural interactions between enhancers and genes in aortic tissue, revealing complex network interactions that contribute to emergent properties of aortic morphology and disease susceptibility.^[1]

Intracellular Signaling Cascades and Vascular Cell Homeostasis

Abnormal aortic morphology often arises from dysregulation in critical intracellular signaling pathways that govern vascular cell function. ThePI3K-Akt signaling pathway is pivotal in the vascular endothelium, influencing endothelial cell proliferation, survival, migration, and nitric oxide production. ^[22] Conversely, the JNKpathway has been implicated in the pathogenesis of abdominal aortic aneurysm, highlighting its role in pathological remodeling.^[22] Furthermore, DAB2IP acts as an endogenous inhibitor of VEGFR2-mediated signaling, a crucial regulator of angiogenesis, demonstrating complex feedback loops that maintain vascular homeostasis but can be dysregulated in disease.^[22]

Receptor-mediated signaling also significantly impacts aortic structure and function. Variants in genes related to the angiotensin-converting enzyme and angiotensin II type 1 receptor, as well as beta-adrenergic receptor genes and endothelin gene variants, have been associated with aortic stiffness.^[20]These receptor activations trigger intracellular signaling cascades that modulate vascular smooth muscle cell tone, proliferation, and extracellular matrix synthesis, thereby affecting arterial wall properties.^[20]Telomerase activity, influenced by telomerase reverse transcriptase, represents a key post-translational regulatory mechanism; its upregulation in the aorta of hypertensive rats and its role in vascular smooth muscle cell proliferation and apoptosis underscore its critical involvement in vascular remodeling and potential as a therapeutic target.^[8]

Extracellular Matrix Remodeling and Aortic Biomechanics

The structural integrity and mechanical properties of the aorta are maintained through a dynamic balance of extracellular matrix synthesis and degradation, a process frequently disrupted in abnormal aortic morphology. The genotype of matrix metalloproteinase-3, for instance, contributes to age-related aortic stiffening by modulating its gene and protein expression, directly impacting the composition and organization of the aortic wall.^[20] This enzymatic activity is a critical component of catabolism and remodeling within the vascular tissue, affecting flux control of matrix components. Genetic variants in genes such as LRP1(low-density lipoprotein receptor-related protein 1) have been associated with abdominal aortic aneurysm, suggesting a role in lipid metabolism or cellular signaling that influences matrix integrity.^[5]

Several other genetic loci are associated with aortic diameter and calcific aortic valve stenosis, reflecting their roles in maintaining aortic biomechanics. Genes like GOSR2, CACNA1C, CFDP1, PALMD, KCNRG, FGGY, TMEM16A, SMG6, CCDC100, and PDE3Aare linked to aortic diameter, blood pressure, myocardial infarction, and coronary artery disease, indicating their systemic influence on vascular health.^[8] Specifically, PALMD has been identified as a susceptibility gene for calcific aortic valve stenosis, illustrating how metabolic regulation and biosynthesis pathways contribute to pathological calcification and altered tissue mechanics. ^[23] These genes collectively highlight the complex network interactions that determine the emergent properties of aortic stiffness and resilience.

Inflammation, Immunity, and Cellular Senescence in Aortic Disease

Aortic pathologies, particularly aneurysms and valvular calcification, are increasingly recognized as having significant inflammatory and immunological components. Aortic aneurysms are characterized as an immune disease with a strong genetic predisposition, where dysregulated immune responses contribute to chronic inflammation and tissue degradation.^[9] In calcific aortic valve stenosis, susceptibility genes such as IL6 (interleukin-6), ALPL(alkaline phosphatase), andNAV1have been identified, indicating the involvement of inflammatory cytokines and enzymes in the disease process.^[23] IL6 plays a central role in inflammatory signaling, while ALPLis involved in bone mineralization and phosphate metabolism, suggesting a metabolic pathway dysregulation that contributes to pathological calcification within the aortic valve.^[23]

The interplay between inflammation, immunity, and cellular senescence contributes to the progressive nature of aortic diseases. Chronic inflammation can trigger feedback loops that perpetuate tissue damage and remodeling, leading to the breakdown of arterial wall components. Moreover, telomerase activity, which influences vascular smooth muscle cell proliferation and apoptosis, is implicated in vascular remodeling and cellular senescence, representing a crucial regulatory mechanism in the context of persistent inflammation and tissue repair.^[8]Understanding these integrated systems-level interactions provides insights into the complex pathophysiology of abnormal aortic morphology and identifies potential therapeutic targets for intervention.

Clinical Relevance

Genetic Predisposition and Early Risk Identification

Abnormal aortic morphology, encompassing conditions like aortic valve stenosis (AS), bicuspid aortic valve (BAV), and various aneurysms, often possesses a significant genetic component, which is crucial for early risk identification and the development of personalized medicine strategies. Genome-wide association studies (GWAS) have identified specific genetic markers associated with these conditions. For instance, thers7543130 variant near PALMDhas been linked to AS, BAV, and an increased aortic root size.^[1] While a missense variant in MYH6strongly associates with BAV, its impact on aortic root size appears to be distinct.^[1] Notably, MYH6 has also been implicated in non-syndromic coarctation of the aorta ^[4] underscoring its broader role in aortic development.

The genetic underpinnings extend beyond isolated conditions, with evidence suggesting shared genetic risk factors across different aortic pathologies, including intracranial, abdominal, and thoracic aneurysms. ^[1]This shared genetic architecture points towards common pathways in disease development and offers potential for comprehensive genetic screening strategies. Identifying individuals with these genetic predispositions allows for proactive monitoring and targeted preventive measures, fostering a personalized medicine approach where risk is stratified based on an individual’s unique genetic profile.^[13] Further research into the genetic component of BAV and aortic dilation, including exome-wide association studies ^[24] continues to enhance the utility of genetic insights in identifying high-risk individuals before overt clinical manifestations.

Prognostic Indicators and Disease Progression

Abnormal aortic morphology serves as a crucial prognostic indicator for various cardiovascular outcomes, guiding predictions of disease progression and long-term implications for patient health. Aortic valve stenosis, for example, is a progressive condition with significant morbidity and mortality, where symptomatic severe AS carries an estimated 5-year survival rate of 15-50% without aortic valve replacement.^[1] The presence of a bicuspid aortic valve (BAV) significantly accelerates the development of AS by decades ^[1]making its early detection vital for understanding and managing the disease trajectory. Beyond valvular issues, arterial stiffness, often assessed by aortic pulse wave velocity, independently predicts all-cause and cardiovascular mortality, as well as the risk of coronary heart disease and stroke.^[20]

Subclinical atherosclerosis in major arterial territories, including abdominal aortic calcification (AAC) and carotid artery intima-media thickness (IMT), are robust predictors of future vascular morbidity and mortality.^[13]Specifically, abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality, while increased carotid IMT is a recognized risk factor for myocardial infarction and stroke.^[13]These morphological abnormalities, identifiable through various imaging and physiological measurements, offer valuable insights into a patient’s cardiovascular risk profile. This enables clinicians to implement appropriate monitoring strategies and early interventions to mitigate adverse long-term outcomes.^[20]

Interconnected Vascular Pathologies and Therapeutic Guidance

The clinical relevance of abnormal aortic morphology extends to its strong associations with other cardiovascular conditions, forming overlapping phenotypes that necessitate comprehensive diagnostic and therapeutic strategies. Aortic valve stenosis shares several clinical risk factors with atherosclerotic disease, and the lesions themselves exhibit characteristic features of atherosclerosis, including initial endothelial damage, oxidized lipid deposition, chronic inflammation, and calcification.^[1] The relationship between BAV and aortopathy is also well-recognized, with proximal ascending aorta dilation often resulting from altered flow dynamics due to the bicuspid valve. ^[1] These interconnections highlight the importance of assessing the entire vascular system in patients presenting with aortic abnormalities.

Diagnostic utility is enhanced by recognizing these associations, allowing for more targeted screening for related conditions. For instance, genetic variants like rs7543130 near PALMDnot only associate with AS and BAV but also with increased aortic root size^[1]providing a genetic link between valvular and aortic wall pathologies. The identification of genetic risk factors for subclinical atherosclerosis, such as SNPs nearFGF1 for AAC or ADRB2for coronary artery calcification^[13] can guide personalized prevention and treatment selection. Understanding these complex interrelationships and the underlying genetic architecture supports a holistic approach to patient care, optimizing treatment selection and monitoring strategies for improved clinical outcomes.

Frequently Asked Questions About Abnormal Aortic Morphology

These questions address the most important and specific aspects of abnormal aortic morphology based on current genetic research.

---

1. My parent had an aneurysm. Will I get one too?

Yes, there’s a good chance. Aneurysms, whether in the brain, abdomen, or chest, often share genetic risk factors that can run in families. Mutations in genes like FBN1 are linked to conditions such as Marfan syndrome, which significantly increases the risk for aortic aneurysms, and other genes like TGFBR1 and TGFBR2 are also known to cause multiple types of aneurysms within families.

2. I’m getting older. Can I prevent my aortic valve from calcifying?

While you can’t completely prevent all calcification, especially as you age, managing risk factors is important. Aortic valve calcification, which leads to aortic stenosis, shares risk factors with heart conditions like atherosclerosis. Genetic variations, such as those at theLPA locus, can also causally increase your risk by affecting lifelong levels of Lp(a), a type of cholesterol.

3. My baby was born with a heart problem. Could it affect their aorta later?

Yes, it’s possible. Some congenital heart defects, like a bicuspid aortic valve (having two valve leaflets instead of three), are present from birth and are known to accelerate the development of aortic valve issues like stenosis decades later. Certain genetic variants, such as a missense variant in theMYH6 gene, are strongly associated with a bicuspid aortic valve and other congenital heart conditions like coarctation of the aorta.

4. I have atrial fibrillation. Does that mean my aorta is also at risk?

There can be a connection. A specific missense variant in the MYH6gene has been linked not only to atrial fibrillation but also to conditions like bicuspid aortic valve and coarctation of the aorta. This suggests that shared genetic pathways can predispose individuals to multiple cardiovascular issues.

5. My friend has a perfect aorta, but mine is abnormal. Why the difference?

Genetics play a substantial role in these differences. Even among people with similar lifestyles, genetic variations can predispose some individuals to conditions like aortic root dilation, aortic valve stenosis, or a bicuspid aortic valve. For example, a variant near the PALMDgene can increase aortic root size and risk for AS and BAV, while a different variant inMYH6 primarily affects BAV.

6. I watch my cholesterol. Does that truly protect my aorta from problems?

Watching your cholesterol is beneficial, as aortic valve stenosis shares risk factors with atherosclerotic disease, including oxidized lipid deposition. However, certain genetic factors can independently increase your risk. For instance, a specific variant at theLPAlocus can causally lead to aortic valve calcification by raising your Lp(a) levels, even if other cholesterol levels are well-controlled.

7. My doctor says I have an enlarged aorta. What does that mean for me?

An enlarged aorta, or aortic root dilation, means your aorta is wider than it should be. This can lead to serious complications like severe aortic regurgitation, where blood leaks backward through the valve. Genetic factors, such as a variant near the PALMD gene or in CFDP1, are known to be associated with increased aortic root size.

8. Could a DNA test tell me my personal risk for these aortic problems?

Potentially, yes. Identifying your genetic predispositions through DNA testing can be valuable. This information can help your doctor establish improved screening protocols for you, intervene earlier if needed, and develop more personalized management strategies to potentially alter the course of the disease and improve your outcomes.

9. What signs should I watch for if I’m worried about an aneurysm?

Aneurysms can be very serious, and while specific symptoms depend on the type and location, early detection is key. Thoracic aortic aneurysms and aortic dissections, for example, are life-threatening emergencies. If you have a family history or known risk factors, regular medical check-ups and discussions with your doctor about screening are crucial, even before symptoms appear.

10. My doctor mentioned a bicuspid valve. How bad is that for my future?

A bicuspid aortic valve is a significant finding because it’s known to accelerate the development of aortic valve stenosis by decades. This means you are at a higher risk of needing interventions like aortic valve replacement earlier in life. Early diagnosis and close monitoring by your doctor are essential to manage this condition effectively and plan for any necessary treatment.

---

This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.

Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.

References

[1] Helgadottir A, et al. “Genome-wide analysis yields new loci associating with aortic valve stenosis.” Nat Commun. 2018; 9:988.

[2] Roman, M. J., et al. “Aortic root dilation as a cause of isolated, severe aortic regurgitation. Prevalence, clinical and echocardiographic patterns, and relation to left ventricular hypertrophy and function.”Ann Intern Med, vol. 106, no. 6, 1987, pp. 800-807.

[3] van ‘t Hof FN, et al. “Shared Genetic Risk Factors of Intracranial, Abdominal, and Thoracic Aneurysms.” J Am Heart Assoc. 2016; 5:e003023.

[4] Bjornsson, T. et al. “A rare missense mutation in MYH6 associates with non-syndromic coarctation of the aorta.” Eur Heart J, vol. 39, no. 16, 2018, pp. 1443–1449.

[5] Bown MJ, et al. “Abdominal aortic aneurysm is associated with a variant in low-density lipoprotein receptor-related protein 1.” Am J Hum Genet. 2011; 89:619–627.

[6] Thanassoulis G, et al. “Genetic associations with valvular calcification and aortic stenosis.” N Engl J Med. 2013; 368:503–512.

[7] LeMaire, S. A., et al. “Genome-wide association study identifies a susceptibility locus for thoracic aortic aneurysms and aortic dissections spanning FBN1 at 15q21.1.” Nat Genet, vol. 43, no. 10, 2011, pp. 996-1000.

[8] Vasan RS, et al. “Genetic variants associated with cardiac structure and function: a meta-analysis and replication of genome-wide association data.” JAMA. 2009; 302:302–316.

[9] Jones, G. T., et al. “Meta-Analysis of Genome-Wide Association Studies for Abdominal Aortic Aneurysm Identifies Four New Disease-Specific Risk Loci.”Circ Res, vol. 119, no. 12, 2016, pp. 1281-1292.

[10] Wineinger, N. E., et al. “Genome-wide joint SNP and CNV analysis of aortic root diameter in African Americans: the HyperGEN study.” BMC Medical Genomics, vol. 4, 2011, p. 3.

[11] Benetos A, Gautier S, Ricard S, Topouchian J, Asmar R, Poirier O, et al. “Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients.” Circulation. 1996; 94:698–703.

[12] Ortlepp JR, Hoffmann R, Ohme F, Lauscher J, Bleckmann F, Hanrath P. “The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis.” Heart. 2001; 85:635–638.

[13] O’Donnell CJ, et al. “Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI’s Framingham Heart Study.” BMC Med Genet. 2007; 8:58.

[14] Gago-Diaz, M. et al. “The genetic component of bicuspid aortic valve and aortic dilation. An exome-wide association study.” J Mol Cell Cardiol, vol. 102, 2017, pp. 3–9.

[15] Garg V, Muth AN, Ransom JF, et al. “Mutations in NOTCH1 cause aortic valve disease.” Nature. 2005; 437:270–274.

[16] Probst V, Le Scouarnec S, Legendre A, et al. “Familial aggregation of calcific aortic valve stenosis in the western part of France.” Circulation. 2006; 113:856–860.

[17] Novaro GM, Sachar R, Pearce GL, Sprecher DL, Griffin BP. “Association between apolipoprotein E alleles and calcific valvular heart disease.” Circulation. 2003; 108:1804–1808.

[18] Chen W, Srinivasan SR, Boerwinkle E, Berenson GS. “Beta-adrenergic receptor genes are associated with arterial stiffness in black and white adults: the Bogalusa Heart Study.” Am J Hypertens. 2007; 20:1251–1257.

[19] Medley TL, Kingwell BA, Gatzka CD, Pillay P, Cole TJ. “Matrix metalloproteinase-3 genotype contributes to age-related aortic stiffening through modulation of gene and protein expression.” Hypertension. 2001; 38:1190–1197.

[20] Mitchell, G. F., et al. “Common genetic variation in the 3’-BCL11B gene desert is associated with carotid-femoral pulse wave velocity and excess cardiovascular disease risk: the AortaGen Consortium.”Circ Cardiovasc Genet, vol. 4, no. 6, 2011, pp. 609-617.

[21] Nordström P, Glader CA, Dahlén G, et al. “Oestrogen receptor α gene polymorphism is related to aortic valve sclerosis in postmenopausal women.” J Intern Med. 2003; 254:140–146.

[22] Gretarsdottir, S., et al. “Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm.”Nat Genet, vol. 42, no. 8, 2010, pp. 692-697.

[23] Theriault, S. et al. “A transcriptome-wide association study identifies PALMD as a susceptibility gene for calcific aortic valve stenosis.” Nat Commun, vol. 9, no. 1, 2018, p. 987.

[24] Gago-Díaz M, et al. “The genetic component of bicuspid aortic valve and aortic dilation. An exome-wide association study.” J Mol Cell Cardiol. 2017; 102:3–9.